PTK2 and cancer: The CCL22-mediated FAK addiction in ESCC cells implies that TME-derived cytokines can prime the responsiveness of cancer cells to protein tyrosine kinase-based targeted therapies by inducing oncogene addiction and indicates that an immunosuppressive TME may be the critical switch to mediate oncogene addiction.